Loading...

Boill Healthcare Holdings

SEHK:1246
Snowflake Description

Fair value with mediocre balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
1246
SEHK
HK$907M
Market Cap
  1. Home
  2. HK
  3. Capital Goods
Company description

Boill Healthcare Holdings Limited, an investment holding company, undertakes contracts for foundation piling in Hong Kong and Mainland China. The last earnings update was 18 days ago. More info.


Add to Portfolio Compare Print
  • Boill Healthcare Holdings has significant price volatility in the past 3 months.
1246 Share Price and Events
7 Day Returns
-4%
SEHK:1246
-1.4%
HK Construction
0.6%
HK Market
1 Year Returns
5.6%
SEHK:1246
-12.3%
HK Construction
-5.9%
HK Market
1246 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Boill Healthcare Holdings (1246) -4% -1% -24% 5.6% -44.1% -78.2%
HK Construction -1.4% -5.6% -14.7% -12.3% -23% -1.8%
HK Market 0.6% 3.7% -8.2% -5.9% 17.2% 4.8%
1 Year Return vs Industry and Market
  • 1246 outperformed the Construction industry which returned -12.3% over the past year.
  • 1246 outperformed the Market in Hong Kong which returned -5.9% over the past year.
Price Volatility
1246
Industry
5yr Volatility vs Market

1246 Value

 Is Boill Healthcare Holdings undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Boill Healthcare Holdings to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Boill Healthcare Holdings.

SEHK:1246 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 12.9%
Perpetual Growth Rate 10-Year HK Government Bond Rate 2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for SEHK:1246
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year HK Govt Bond Rate 2%
Equity Risk Premium S&P Global 6.7%
Construction Unlevered Beta Simply Wall St/ S&P Global 1.04
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.043 (1 + (1- 25%) (115.98%))
1.637
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.64
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2% + (1.637 * 6.65%)
12.89%

Discounted Cash Flow Calculation for SEHK:1246 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Boill Healthcare Holdings is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

SEHK:1246 DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (HKD, Millions) Source Present Value
Discounted (@ 12.89%)
2020 308.53 Est @ 7.34% 273.31
2021 326.23 Est @ 5.74% 256.00
2022 341.29 Est @ 4.62% 237.24
2023 354.37 Est @ 3.83% 218.22
2024 366.00 Est @ 3.28% 199.65
2025 376.62 Est @ 2.9% 181.99
2026 386.52 Est @ 2.63% 165.46
2027 395.96 Est @ 2.44% 150.15
2028 405.11 Est @ 2.31% 136.08
2029 414.10 Est @ 2.22% 123.22
Present value of next 10 years cash flows HK$1,941.31
SEHK:1246 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= HK$414.10 × (1 + 2%) ÷ (12.89% – 2%)
HK$3,881.03
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= HK$3,881.03 ÷ (1 + 12.89%)10
HK$1,154.85
SEHK:1246 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= HK$1,941.31 + HK$1,154.85
HK$3,096.15
Equity Value per Share
(HKD)
= Total value / Shares Outstanding
= HK$3,096.15 / 9,074.00
HK$0.34
SEHK:1246 Discount to Share Price
Calculation Result
Value per share (HKD) From above. HK$0.34
Current discount Discount to share price of HK$0.10
= -1 x (HK$0.10 - HK$0.34) / HK$0.34
72.2%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Boill Healthcare Holdings is available for.
Intrinsic value
>50%
Share price is HK$0.095 vs Future cash flow value of HK$0.34121
Current Discount Checks
For Boill Healthcare Holdings to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Boill Healthcare Holdings's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Boill Healthcare Holdings's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Boill Healthcare Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Boill Healthcare Holdings's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
SEHK:1246 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in HKD HK$-0.02
SEHK:1246 Share Price ** SEHK (2019-07-16) in HKD HK$0.1
Hong Kong Construction Industry PE Ratio Median Figure of 105 Publicly-Listed Construction Companies 9.77x
Hong Kong Market PE Ratio Median Figure of 1,503 Publicly-Listed Companies 10.71x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Boill Healthcare Holdings.

SEHK:1246 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= SEHK:1246 Share Price ÷ EPS (both in HKD)

= 0.1 ÷ -0.02

-4.31x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Boill Healthcare Holdings is loss making, we can't compare its value to the HK Construction industry average.
  • Boill Healthcare Holdings is loss making, we can't compare the value of its earnings to the Hong Kong market.
Price based on expected Growth
Does Boill Healthcare Holdings's expected growth come at a high price?
Raw Data
SEHK:1246 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -4.31x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Hong Kong Construction Industry PEG Ratio Median Figure of 10 Publicly-Listed Construction Companies 0.55x
Hong Kong Market PEG Ratio Median Figure of 477 Publicly-Listed Companies 0.8x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Boill Healthcare Holdings, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Boill Healthcare Holdings's assets?
Raw Data
SEHK:1246 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in HKD HK$0.07
SEHK:1246 Share Price * SEHK (2019-07-16) in HKD HK$0.1
Hong Kong Construction Industry PB Ratio Median Figure of 136 Publicly-Listed Construction Companies 1.39x
Hong Kong Market PB Ratio Median Figure of 2,190 Publicly-Listed Companies 0.92x
SEHK:1246 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= SEHK:1246 Share Price ÷ Book Value per Share (both in HKD)

= 0.1 ÷ 0.07

1.35x

* Primary Listing of Boill Healthcare Holdings.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Boill Healthcare Holdings is good value based on assets compared to the HK Construction industry average.
X
Value checks
We assess Boill Healthcare Holdings's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Construction industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Construction industry average (and greater than 0)? (1 check)
  5. Boill Healthcare Holdings has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

1246 Future Performance

 How is Boill Healthcare Holdings expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Boill Healthcare Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
6.4%
Expected Construction industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Boill Healthcare Holdings expected to grow at an attractive rate?
  • Unable to compare Boill Healthcare Holdings's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Boill Healthcare Holdings's earnings growth to the Hong Kong market average as no estimate data is available.
  • Unable to compare Boill Healthcare Holdings's revenue growth to the Hong Kong market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
SEHK:1246 Future Growth Rates Data Sources
Data Point Source Value (per year)
Hong Kong Construction Industry Earnings Growth Rate Market Cap Weighted Average 6.4%
Hong Kong Construction Industry Revenue Growth Rate Market Cap Weighted Average 9.6%
Hong Kong Market Earnings Growth Rate Market Cap Weighted Average 11.3%
Hong Kong Market Revenue Growth Rate Market Cap Weighted Average 10.5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
SEHK:1246 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in HKD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
SEHK:1246 Future Estimates Data
Date (Data in HKD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
SEHK:1246 Past Financials Data
Date (Data in HKD Millions) Revenue Cash Flow Net Income *
2019-03-31 420 -200
2018-12-31 572 -205
2018-09-30 724 388 -210
2018-06-30 731 342 -199
2018-03-31 738 297 -188
2017-12-31 616 -298
2017-09-30 459 11 -412
2017-06-30 473 -73 -491
2017-03-31 487 -157 -570
2016-12-31 492 -308 -450
2016-09-30 485 -371 -327
2016-06-30 509 -313 -260

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Boill Healthcare Holdings is high growth as no earnings estimate data is available.
  • Unable to determine if Boill Healthcare Holdings is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
SEHK:1246 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Boill Healthcare Holdings Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SEHK:1246 Future Estimates Data
Date (Data in HKD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
SEHK:1246 Past Financials Data
Date (Data in HKD Millions) EPS *
2019-03-31 -0.02
2018-12-31 -0.02
2018-09-30 -0.02
2018-06-30 -0.02
2018-03-31 -0.02
2017-12-31 -0.04
2017-09-30 -0.05
2017-06-30 -0.08
2017-03-31 -0.12
2016-12-31 -0.13
2016-09-30 -0.15
2016-06-30 -0.17

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Boill Healthcare Holdings will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine whether Boill Healthcare Holdings is trading at Boill Healthcare Holdings'san attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
  2. Boill Healthcare Holdings's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Capital Goods companies here
  3. Boill Healthcare Holdings's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Boill Healthcare Holdings's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Hong Kong market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Hong Kong market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Boill Healthcare Holdings has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

1246 Past Performance

  How has Boill Healthcare Holdings performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Boill Healthcare Holdings's growth in the last year to its industry (Construction).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Boill Healthcare Holdings does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Boill Healthcare Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Boill Healthcare Holdings's 1-year growth to the HK Construction industry average as it is not currently profitable.
Earnings and Revenue History
Boill Healthcare Holdings's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Boill Healthcare Holdings Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SEHK:1246 Past Revenue, Cash Flow and Net Income Data
Date (Data in HKD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 419.76 -200.11 92.72
2018-12-31 571.67 -205.12 105.35
2018-09-30 723.57 -210.12 117.98
2018-06-30 730.86 -198.92 123.20
2018-03-31 738.15 -187.73 128.41
2017-12-31 616.48 -297.77 122.12
2017-09-30 459.05 -411.83 98.34
2017-06-30 473.09 -491.15 93.55
2017-03-31 487.12 -570.48 88.76
2016-12-31 492.17 -449.62 102.38
2016-09-30 484.93 -326.86 110.15
2016-06-30 508.56 -260.13 98.62
2016-03-31 532.19 -193.39 87.09
2015-12-31 512.04 -113.31 79.76
2015-09-30 491.89 -33.22 72.43
2015-06-30 525.02 28.67 66.79
2015-03-31 558.15 90.56 61.16
2014-12-31 562.30 84.26 55.70
2014-09-30 566.45 77.95 50.24
2014-06-30 526.68 75.67 48.76
2014-03-31 486.91 73.38 47.29
2013-12-31 440.90 68.84 36.60
2013-09-30 394.89 64.30 25.91
2013-06-30 375.49 63.36 23.53
2013-03-31 356.10 62.42 21.14

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Boill Healthcare Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Boill Healthcare Holdings has efficiently used its assets last year compared to the HK Construction industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Boill Healthcare Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Boill Healthcare Holdings's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Construction industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Boill Healthcare Holdings has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

1246 Health

 How is Boill Healthcare Holdings's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Boill Healthcare Holdings's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Boill Healthcare Holdings's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Boill Healthcare Holdings's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Boill Healthcare Holdings's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Boill Healthcare Holdings Company Filings, last reported 3 months ago.

SEHK:1246 Past Debt and Equity Data
Date (Data in HKD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 1,191.56 1,052.41 68.24
2018-12-31 1,191.56 1,052.41 68.24
2018-09-30 1,341.63 1,205.41 309.93
2018-06-30 1,341.63 1,205.41 309.93
2018-03-31 1,558.79 1,208.48 225.33
2017-12-31 1,558.79 1,223.54 225.33
2017-09-30 1,621.13 1,206.46 220.37
2017-06-30 1,621.13 1,206.46 220.37
2017-03-31 553.30 853.00 532.66
2016-12-31 553.30 851.77 536.39
2016-09-30 923.36 842.03 679.46
2016-06-30 923.36 842.03 679.46
2016-03-31 189.04 1,234.87 348.96
2015-12-31 189.04 1,234.87 348.96
2015-09-30 300.15 146.14 313.69
2015-06-30 300.15 146.14 313.69
2015-03-31 321.42 132.07 321.49
2014-12-31 321.42 132.07 321.49
2014-09-30 271.17 17.09 102.55
2014-06-30 271.17 17.09 102.55
2014-03-31 229.30 22.00 118.64
2013-12-31 229.30 22.00 118.64
2013-09-30 93.27 26.84 54.02
2013-06-30 93.27 26.84 54.02
2013-03-31 95.98 13.35 67.21
  • Boill Healthcare Holdings's level of debt (88.3%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (11.5% vs 88.3% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Whilst loss making Boill Healthcare Holdings has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
  • Whilst loss making Boill Healthcare Holdings has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -128.3% per year.
X
Financial health checks
We assess Boill Healthcare Holdings's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Boill Healthcare Holdings has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

1246 Dividends

 What is Boill Healthcare Holdings's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Boill Healthcare Holdings dividends.
If you bought HK$2,000 of Boill Healthcare Holdings shares you are expected to receive HK$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Boill Healthcare Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Boill Healthcare Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
SEHK:1246 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Hong Kong Construction Industry Average Dividend Yield Market Cap Weighted Average of 43 Stocks 3.9%
Hong Kong Market Average Dividend Yield Market Cap Weighted Average of 978 Stocks 3.6%
Hong Kong Minimum Threshold Dividend Yield 10th Percentile 1.2%
Hong Kong Bottom 25% Dividend Yield 25th Percentile 2.1%
Hong Kong Top 25% Dividend Yield 75th Percentile 5.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

SEHK:1246 Future Dividends Estimate Data
Date (Data in HK$) Dividend per Share (annual) Avg. No. Analysts

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Boill Healthcare Holdings has not reported any payouts.
  • Unable to verify if Boill Healthcare Holdings's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Boill Healthcare Holdings's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Boill Healthcare Holdings has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Boill Healthcare Holdings's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Boill Healthcare Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Boill Healthcare Holdings has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

1246 Management

 What is the CEO of Boill Healthcare Holdings's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
  • Boill Healthcare Holdings has no CEO, or we have no data on them.
Management Team

Dong Xing Dai

TITLE
Chairman
COMPENSATION
HK$2M
AGE
56

Sheng Hai Zhang

TITLE
Executive Director
COMPENSATION
HK$968K
AGE
42

Yuk Chong

TITLE
Company Secretary
AGE
38
TENURE
0.6 yrs
Board of Directors Tenure

Average tenure and age of the Boill Healthcare Holdings board of directors in years:

1.9
Average Tenure
54
Average Age
  • The average tenure for the Boill Healthcare Holdings board of directors is less than 3 years, this suggests a new board.
Board of Directors

Dong Xing Dai

TITLE
Chairman
COMPENSATION
HK$2M
AGE
56
TENURE
1.9 yrs

Sheng Hai Zhang

TITLE
Executive Director
COMPENSATION
HK$968K
AGE
42
TENURE
1.9 yrs

Liang Wei Xu

TITLE
Independent Non-Executive Director
COMPENSATION
HK$76K
AGE
64
TENURE
1.9 yrs

Billy Chan

TITLE
Independent Non-Executive Director
COMPENSATION
HK$45K
AGE
45
TENURE
1.7 yrs

Kwong Kau Chui

TITLE
Non-Executive Director
COMPENSATION
HK$120K
AGE
52
TENURE
4.3 yrs

Zhe Wang

TITLE
Independent Non-Executive Director
COMPENSATION
HK$76K
AGE
59
TENURE
1.9 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (HK$) Value (HK$)
X
Management checks
We assess Boill Healthcare Holdings's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Boill Healthcare Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

1246 News

Simply Wall St News

Boill Healthcare Holdings (HKG:1246) Has Us Worried With Its Last Reported Debt Levels

We can see that Boill Healthcare Holdings Limited (HKG:1246) does use debt in its business. … You can click the graphic below for the historical numbers, but it shows that Boill Healthcare Holdings had HK$1.05b of debt in March 2019, down from HK$1.21b, one year before On the flip side, it has HK$68.2m in cash leading to net debt of about HK$984.2m. … SEHK:1246 Historical Debt, July 11th 2019 A Look At Boill Healthcare Holdings's Liabilities Zooming in on the latest balance sheet data, we can see that Boill Healthcare Holdings had liabilities of HK$1.28b due within 12 months and liabilities of HK$102.7m due beyond that.

Simply Wall St -

Do Insiders Own Lots Of Shares In Boill Healthcare Holdings Limited (HKG:1246)?

Every investor in Boill Healthcare Holdings Limited (HKG:1246) should be aware of the most powerful shareholder groups. … Boill Healthcare Holdings is a smaller company with a market capitalization of HK$962m, so it may still be flying under the radar of many institutional investors. … Taking a look at our data on the ownership groups (below), it's seems that.

Simply Wall St -

What Investors Should Know About Boill Healthcare Holdings Limited's (HKG:1246) Financial Strength

While small-cap stocks, such as Boill Healthcare Holdings Limited (HKG:1246) with its market cap of HK$1.2b, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn. … the current state of its operations and pathway to profitability.

Simply Wall St -

Did You Manage To Avoid Boill Healthcare Holdings's Devastating 85% Share Price Drop?

Spare a thought for anyone who held Boill Healthcare Holdings Limited (HKG:1246) for five whole years - as the share price tanked 85%. … In the last five years Boill Healthcare Holdings improved its bottom line results, having previously been loss-making. … A more detailed examination of the revenue and earnings may or may not explain why the share price languishes; there could be an opportunity

Simply Wall St -

Is Boill Healthcare Holdings Limited's (HKG:1246) Balance Sheet Strong Enough To Weather A Storm?

Boill Healthcare Holdings Limited (HKG:1246) is a small-cap stock with a market capitalization of HK$608m. … While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health.

Simply Wall St -

What does Boill Healthcare Holdings Limited's (HKG:1246) Balance Sheet Tell Us About Its Future?

Investors are always looking for growth in small-cap stocks like Boill Healthcare Holdings Limited (HKG:1246), with a market cap of HK$771.29m. … However, an important fact which most ignore is: how financially healthy is the business? … the current state of its operations and pathway to profitability.

Simply Wall St -

With A -25.67% Earnings Drop, Did Boill Healthcare Holdings Limited (HKG:1246) Really Underperform?

Assessing Boill Healthcare Holdings Limited's (SEHK:1246) performance as a company requires looking at more than just a years' earnings data. … Below, I will run you through a simple sense check to build perspective on how Boill Healthcare Holdings is doing by comparing its most recent earnings with its historical trend, in addition to the performance of its construction industry peers. … For Boill Healthcare Holdings, its most recent trailing-twelve-month earnings is -HK$410.78M, which compared to the previous year's figure, has become more negative.

Simply Wall St -

What Investors Should Know About Boill Healthcare Holdings Limited's (HKG:1246) Financial Strength

Moving onto cash from operations, its operating cash flow is not yet significant enough to calculate a meaningful cash-to-debt ratio, indicating that operational efficiency is something we’d need to take a look at. … Running high debt, while not yet making money, can be risky in unexpected downturns as liquidity may dry up, making it hard to operate.Next Steps: 1246’s debt and cash flow levels indicate room for improvement. … Its cash flow coverage of less than a quarter of debt means that operating efficiency could be an issue.

Simply Wall St -

Who Owns Boill Healthcare Holdings Limited (HKG:1246)?

Check out our latest analysis for Boill Healthcare Holdings SEHK:1246 Ownership_summary Feb 21st 18 Institutional Ownership Institutional investors typically buy and sell shares in large magnitudes which can significantly sway the share price, especially when there are relatively small amounts of shares available on the market to trade. … With this size of ownership, retail investors can collectively play a role in major company policies that affect shareholders returns, including executive remuneration and the appointment of directors. … Thus, investors not need worry too much about the consequences of these holdings.Next Steps: With a low level of institutional ownership, investors in 1246 need not worry about non-fundamental factors such as ownership structure causing large impact on stock prices.

Simply Wall St -

Should You Be Concerned About Boill Healthcare Holdings Limited's (HKG:1246) Risks?

A widely-used metric to measure a stock's market risk is beta, and the broad market index represents a beta value of one. … View our latest analysis for Boill Healthcare Holdings An interpretation of 1246's beta With a beta of 4.09, Boill Healthcare Holdings is a stock that tends to experience more gains than the market during a growth phase and also a bigger reduction in value compared to the market during a broad downturn. … A market capitalisation of HK$1.04B puts 1246 in the category of small-cap stocks, which tends to possess higher beta than larger companies.

Simply Wall St -

1246 Company Info

Description

Boill Healthcare Holdings Limited, an investment holding company, undertakes contracts for foundation piling in Hong Kong and Mainland China. It operates through four segments: Foundation Piling, Property Development, Investment Securities, and Healthcare Holiday Resort Development and Operation. The company develops and sells properties, as well as provides property management services. In addition, it trades and invests in securities; and provides elderly home care, healthcare, and leisure services. The company was formerly known as Ngai Shun Holdings Limited and changed its name to Boill Healthcare Holdings Limited in September 2017. Boill Healthcare Holdings Limited was founded in 1983 and is headquartered in Sheung Wan, Hong Kong.

Details
Name: Boill Healthcare Holdings Limited
1246
Exchange: SEHK
Founded: 1983
HK$907,400,000
9,074,000,000
Website: http://www.boillhealthcare.com.hk
Address: Boill Healthcare Holdings Limited
Shun Tak Centre West Tower,
Unit 2603, 26th Floor,
Sheung Wan,
Hong Kong
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
SEHK 1246 Ordinary Shares The Stock Exchange of Hong Kong Ltd. HK HKD 16. Oct 2013
Number of employees
Current staff
Staff numbers
141
Boill Healthcare Holdings employees.
Industry
Construction and Engineering
Capital Goods
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/07/16 13:01
End of day share price update: 2019/07/16 00:00
Last estimates confirmation: 2018/06/27
Last earnings filing: 2019/06/28
Last earnings reported: 2019/03/31
Last annual earnings reported: 2019/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.